Lift Mobile Mindfulness for COVID-19 Distress Symptoms (LIFTCOVID)
COVID-19, Cardiorespiratory Failure
About this trial
This is an interventional supportive care trial for COVID-19 focused on measuring critical illness, psychological distress, depression, anxiety, adults
Eligibility Criteria
BLUE CORAL eligibility (the parent cohort study from which RCT participants will be recruited)
Inclusion criteria:
- Adult hospitalized within 14 days of a positive PCR test for COVID-19
- Evidence of acute COVID-19, with fever or respiratory manifestations, as characterized by signs and symptoms such as cough, dyspnea, tachypnea, hypoxemia, and infiltrates on chest imaging.
Exclusion criteria:
- Lack of informed consent
- More than 72 hours of continuous hospitalization.
- Comfort care orders in place at the time of enrollment and/or unexpected to survive for 24 hours
- Prisoners
- Previous enrollment in BLUE CORAL
LIFT COVID RCT eligibility
Inclusion criteria:
- Enrolled in BLUE CORAL
- Survival to time of BLUE CORAL 1-month post-discharge interview
2. English-speaking 3. Domiciled with access to a working telephone and smartphone, tablet, or computer with wifi or internet connection 4. Absence of severe dementia or cognitive dysfunction either before hospitalization or at time of 1 month post-discharge interview
Exclusion criteria:
- PHQ-9 <5 at time of interview 1 month post-discharge
- Suicidal ideation at time of interview 1 month post-discharge
Sites / Locations
- University of Colorado - Denver
- University of Michigan
- Duke University Medical Center
- Oregon Health & Sciences University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Lift mobile mindfulness program
Usual care control
Will receive standard dose Lift mobile mindfulness program intervention content, app-based response to elevated symptoms, and no introductory call from a therapist. This program lasts 1 month and includes 4 unique weeks' worth of audio, video, and text content.
Usual care.